These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25803365)

  • 1. Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory Diseases: Erratum.
    Medicine (Baltimore); 2015 Feb; 94(8):1. PubMed ID: 25803365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.
    Marzano AV; Ceccherini I; Gattorno M; Fanoni D; Caroli F; Rusmini M; Grossi A; De Simone C; Borghi OM; Meroni PL; Crosti C; Cugno M
    Medicine (Baltimore); 2014 Dec; 93(27):e187. PubMed ID: 25501066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
    Huang J; Tsang LS; Shi W; Li J
    Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.
    Braun-Falco M; Kovnerystyy O; Lohse P; Ruzicka T
    J Am Acad Dermatol; 2012 Mar; 66(3):409-15. PubMed ID: 21745697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes.
    Saternus R; Schwingel J; Müller CSL; Vogt T; Reichrath J
    J Transl Autoimmun; 2020; 3():100071. PubMed ID: 33305249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
    Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
    Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
    Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
    Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
    De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.
    Marzano AV; Ishak RS; Colombo A; Caroli F; Crosti C
    Dermatology; 2012; 225(3):215-9. PubMed ID: 23171584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
    Bruzzese V
    J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis.
    Niv D; Ramirez JA; Fivenson DP
    JAAD Case Rep; 2017 Jan; 3(1):70-73. PubMed ID: 28203623
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
    Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interleukin-1β in pyoderma gangrenosum.
    Galimberti RL; Vacas AS; Bollea Garlatti ML; Torre AC
    JAAD Case Rep; 2016 Sep; 2(5):366-368. PubMed ID: 27709123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe acne in autoinflammatory diseases].
    Faleri S; Feichtner K; Ruzicka T
    Hautarzt; 2016 Nov; 67(11):897-901. PubMed ID: 27448064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome.
    Lamiaux M; Dabouz F; Wantz M; Lebas D; Lasek A; Courivaud D; Modiano P
    JAAD Case Rep; 2018 Jan; 4(1):17-21. PubMed ID: 29296643
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
    Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome.
    Calderón-Castrat X; Bancalari-Díaz D; Román-Curto C; Romo-Melgar A; Amorós-Cerdán D; Alcaraz-Mas LA; Fernández-López E; Cañueto J
    Br J Dermatol; 2016 Jul; 175(1):194-8. PubMed ID: 26713508
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
    Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
    Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.